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Abstract We have employed the circular dichroism (CD) tech- 
nique to characterize the solution structure of CAP18~o6_~37, a 
lipopolysaccharide (LPS) binding, antimicrobial protein, and its 
interaction with lipid A. Our results revealed that CAP181o6_137 
may exist in at least three lipid A concentration-dependent, pri-
marily helix conformations. The 'model' structure of CAP181o6_~37 
in 30% (v/v) TFE, determined by nuclear magnetic resonance 
(NMR) technique, was found to be a complete and very rigid 
helix. In this conformation, the cationic and hydrophobic groups 
of CAP18~o6_137 are separated into patches and stripes in such a 
way that it can favorably interact with lipid A through either 
coulombic interaction with the diphosphoryl groups or hydropho- 
bic interaction with the fatty acyl chains. 
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1. Introduction 
Endotoxins are lipopolysaccharides which form the main 
constituents of the outer leaflet of Gram-negative bacteria and 
perform vital functions. When librated they are potent mam- 
malian toxins for mammalian cells, stimulating macrophages 
and endothelial cells to release inflammatory mediators uch as 
tumor necrosis factor (TNF) and free radicals [1]. A rational 
approach to the control of inflammation caused by Gram- 
negative bacteria is to counteract the deleterious effects of LPS. 
One therapeutic approach is to identify proteins other than 
antibodies that bind to and neutralize LPS. Several such pro- 
teins have been identified, including Limulus anti-LPS factor 
(LALF) [2], human LPS binding protein (LBP) [3], bactericidal 
permeability increasing protein (BPI, CAP57) [4] and CAP18 
[5]. Although many antimicrobial peptide structures have been 
determined, LALF is the only endotoxin binding protein to 
have had its 3D structure determined [6]. Furthermore, the 
structure of the LPS-binding protein/lipid A complex has re- 
mained elusive. 
CAP18 is a lipopolysaccharide (LPS) binding protein first 
isolated from rabbit granulocytes [5]. Its amino acid sequence, 
deduced from cDNA clones, reveals a mature protein of 142 
residues [7] which has no homology to known LPS binding 
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proteins including CAP57/BPI, bacterial permeability increas- 
ing protein and other LPS binding proteins. The protein is 
composed of two domains: an N-terminal portion of unknown 
function and a C-terminal fragment of 37 amino acids 
(CAP18106 142) that has LPS binding activity [8]. This fragment 
also has potent anti-microbial activity against both Gram-neg- 
ative and Gram-positive bacteria [9]. A more potent fragment, 
CAP18106_J37, was identified by one of us [9] and used for the 
present studies. Recently a 21-amino acid peptide correspond- 
ing to residues 106-126 (CAP18106_ 126) has been shown to have 
potent anti-Gram-positive and anti-Gram-negative bacterial 
activity [10]. Interestingly, the peptide mediates this activity via 
a remarkable permeabilizing effect on the inner membrane of 
E. coli [10]. The structure-function relationship of this peptide 
is still not clear. Here we report a combined CD and NMR 
study on the solution conformations of free and lipid A-bound 
CAP18106_137 in various solvents. We show that indeed the pep- 
tide adapts a helical conformation when bound to lipid A iso- 
lated from Salmonella minnesota R595 strain. 
2. Materials and methods 
2.1. Materials 
The amino acid sequence of CAP1810~t37 is shown below: 
GLRKR LRKFR NKIKE KLKKI GQKIQ GLLPK LA 
This peptide was synthesized with an Applied Biosystems model 430A 
or 431A peptide synthesizer and purified and characterized asdescribed 
previously [8]. Lipid A (Refined Standard Endotoxin from Salmonella 
minnesota R595) was purchased from RIBI Imunochem Research Inc. 
(Hamilton, Montana, USA). Trifluoroethanol-d3 (TFE) was pur- 
chased from Cambridge Isotope (Woburn, MA, USA). Unless other- 
wise stated, all reagents and solvents were obtained commercially as 
reagent grade and used without further purification. 
2.2. Circular dichroism 
Lipid A stock solution (100/tM) was prepared by dissolving the 
appropriate amount of diphosphoryl lipid A in 1 mM sodium phos- 
phate buffer, pH 7.0, containing 1mM NaCI. The solution was swirled 
in a 60°C water bath for 30 s, then sonicated for 30 s. All CD experi- 
ments were carried out in 1 mM sodium phosphate buffer, pH 7.0, 
containing 1 mM NaC1 and the appropriate amount of protein and 
TFE. CD experiments were carried out on a Jasco-J-720 CD spectrom- 
eter. Jasco Model 120-10 cylindrical quartz cell cuvettes with path- 
lengths of 1 or 10 mm were used. The parameters employed were: band 
width -- 2 nm; slit width = sensitivity = 10 mdeg; response = 1 S; scan 
speed = 10 nm/min; scan width = 320-180 nm; step resolution = 0.5 
nm. Temperature within the sample chamber was maintained at 28°C 
with a continuous nitrogen flow rate of 30-40 l/min. The absorbance 
spectrum was monitored while recording a CD spectrum to make sure 
enough light passed through the sample, especially at a wavelength 
below 200 nm. All spectra were an average of 4 scans, and processed 
by a J-720 noise reduction computer program. Reference spectra, ob- 
tained with samples containing all components except the protein, were 
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recorded after each spectrum and subtracted from the protein spectra. 
CD spectra were recorded in mDegree units. Conversion from mDegree 
to Ae was calibrated with (1S)-(+)-10-camphorsulfonic acid (CSA) by 
measuring the absorbance of CSA at 285 nm (absorption extinction 
coefficient = 34.5) and the CD spectrum at 290.5 nm (CD absorption 
coefficient = 2.36). The secondary structure was estimated from the CD 
spectra ccording to the method of Sreerama nd Woody [11]. 
2.3. NMR experiments 
Samples for NMR experiments were prepared by dissolving 3mg of 
CAP1810~137 in 0.35 ml of 50 mM phosphate buffer containing 30% 
TFE-d3, 60% H20 and 10% D20. The pH of this sample was measured 
to be 3.5 (uncorrected). For amide proton exchange rate experiments 
the above NMR sample was lyophilized and redissolved in 30% TFE- 
d3/70% D20. All NMR spectra were obtained on a Bruker AMX600 
spectrometer. All TOCSY (mixing time 80 ms with no trim pulse) and 
DQF COSY spectra were collected with 32 transients and 800 t~ incre- 
ments. All NOESY experiments (mixing times of 80, 100 and 300 ms) 
were collected with 48 transients and 700 t~ increments. Spectra were 
recorded in TPPI mode. The spectral width was 7042 Hz. Water sup- 
pression was achieved by presaturation during recycle delay (1.4 S), and 
during the mixing time for the NOESY experiments. All data were 
processed on a Silicon graphic work station model 4D35/TG using 
Felix (Hare Research Inc.) or Bruker UXNMR programs. Prior to 
Fourier transformation f the free induction decays a skewed sine bell 
window function was applied to both dimensions. When quantitative 
measurements of cross-peak volumes were needed, 90°-shifted sine 
bells were applied in both dimensions. Data were zero-filled to 2K x 2K 
'real' matrix with a digital resolution of 1.72 Hz/pt (Table 1). 
3. Results and discussion 
3.1. CAP181o 6 137 - lipid A interaction 
Fig. la shows the CD spectra of 20/.tM CAP181o6_137, with 
the contr ibut ion from lipid A subtracted, in the presence of 
various amounts of lipid A. The helical contents estimated from 
these spectra show that in the absence of lipid A, CAP18106_137 
is in an unordered state. Addit ion of lipid A caused a increase 
in the formation of helical structure, as monitored by the depth 
of the two valleys at 207 nm and 220 nm and a peak at 192 nm 
in the CD spectra. Another  prominent feature of these CD 
spectra is the lack of single isosbestic point for all curves. 
However, a single isosbestic point was observed when 
CAP1810~I37 was added stepwise to lipid A sample fixed at 
20 I2M concentration (Fig. lb), suggesting that at fixed lipid A 
concentrat ion the CAPl8106_137 molecule can exist in only two 
conformers, the bound helical form and the free random coil 
form. No change in the CD spectrum of free protein was ob- 
served when protein concentrat ion was varied from 1 to 
100/2M. The CD spectrum of lipid A is weak and noisy. Neverthe- 
less, discernible change was detected in the concentrat ion range 
of 25 35/ IM. Thus, we attr ibute the lack of isosbestic point in 
Fig. la to structural changes, possibly mult imer formation, in 
lipid A at higher concentration. Apparently, the structure of 
CAP18106 137 bound to monomeric lipid A is different from that 
bound to polymeric lipid A complex. As a result, there exist at 
least three lipid A concentrat ion-dependent protein conform- 
ers, an unordered conformer in the absence of lipid A, a highly 
helical conformer at high lipid A concentration, and an inter- 
mediate conformer(s) at intermediate lipid A concentration. 
The presence of an intermediate structure for CAPlSio6_137 is 
further supported by the observation of non-monotonic  change 
in the depth of the valley at 227 nm, as shown clearly in the CD 
Table 1 
~H chemical shifts for CAP1810w137 in 30% TFE at 302 K at pH 3.5, taking TMS resonance (0.00 ppm) as a reference 
Residues Chemical shift (ppm) 
HN Hc~ Hfl Hy Others 
Gly t 4.06,3.91 - - 
Leu 2 8.79 4.17 1.66,1.66 1.66 
Arg 3 8.58 4.01 1.96,1.90 1.78,1.71 
Lys 4 8.17 4.05 1.88,1.88 1.57,1.43 
Arg 5 7.92 4.07 2.03,2.03 1.69,1.69 
Leu 6 8.44 4.27 1.83,1.63 1.75 
Arg 7 8.10 4.03 1.95,1.79 1.66,1.66 
Lys s 8.00 4.13 1.92,1.88 1.56,1.49 
Phe 9 8.33 4.37 3.28,3.28 
Arg l° 8.59 3.88 1.96,1.87 1.65,1.65 
Asn II 8.13 4.51 2.99,2.87 - 
Lys m2 8.00 4.12 2.01,1.92 1.49,1.49 
Ile 13 8.00 3.70 1.90 1.35,1.00 
Lys 14 8.13 3.90 1.93,1.93 1.42,1.42 
Glu ~5 7.94 4.06 2.28,2.19 2.62,2.51 
Lys 16 7.96 4.17 1.93,1.93 1.41,1.41 
Leu t7 8.54 4.10 1.89,1.48 1.65 
Lys 18 8.17 4.05 1.96,1.96 1.43,1.43 
Lys 19 7.83 4.14 2.07,1.95 1.51,1.51 
Ile 2° 8.36 3.80 1.96 1.75,1.16 
Gly 21 8.44 3.90,3.79 
Gln 22 8.02 4.13 2.28,2.18 2.62,2.43 
Lys 23 7.94 4.19 2.01,2.01 1.58,1.48 
Ile 24 8.33 3.88 2.01 1.68,1.27 
Gln 25 8.13 4.02 2.20,2.18 2.55,2.43 
Gly 26 7.84 4.09,3.87 
Leu 27 7.84 4.44 1.85,1.68 1.79 
Leu 28 7.78 4.30 1.88,1.57 1.71 
Pro 29 - 4.35 2.37,1.83 2.12,1.99 
Lys 3° 7.67 4.26 1.93,1.93 1.54,1.48 
Leu 31 7.90 4.27 1.72,1.57 1.71 
Ala 32 8.03 4.24 1.41 - 
0.97,0.93 
6CH2 3.23,3.23 eNH 7.36 
8CH 2 1.75,1.75 eCH 2 3.02,3.02 
8CH2 3.16,3.16 eNH 7.25 
0.94,0.89 
6CH2 3.21,3.21 eNH 7.36 
8CH2 1.70,1.70 eCH2 2.97,2.97 
2,6H 7.23, 3,5H 7.29, 4H 7.25 
8CH 2 3.19,3.19 eNH 7.22 
NH2 7.62,6.92 
6CH2 1.71,1.60 eCH 2 2.98,2.98 
T~ 0.85, 8 0.65 
6CH: 1.71,1.71 eCH 2 2.96,2.96 
6CH2 1.77,1.77 eCH 2 2.97,2.97 
0.85,0.85 
8CH2 1.70,1.61 eCH2 2.96,2.96 
8CH 2 1.74,1.74 eCH 2 3.00,3.00 
Y2 0.95, 8 0.87 
NH2 7.42,6.78 
8CH 2 1.71,1.60 eCH 2 2.94,2.94 





6CH 2 1.71,1.71 ~CH2 3.01,3.01 
0.90,0.87 
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Fig. l. (a) CD spectra ofCAP18106_137 in various lipid A concentrations. 
Samples employed for the present study contain 20/.tM of CAP18106_~37 
in 1 mM phosphate buffer, pH 7.0. Lipid A was prepared as described 
in the text. CD spectra were obtained at 28°C. (b) CD spectra of various 
concentrations of CAP18t06-~37 in 20~tM of lipid A. All other conditions 
are the same as in Fig. 2a. A CD spectrum of 20/IM CAP18;06-~37 in 
30% (v/v) of TFE is also included in Fig. la. 
spectrum of the sample with 24/zM lipid A. Transition between 
the two lipid A-bound coformers occurs at lipid A concentra- 
tion around 20-35 pM. 
3.2. NMR resonance assignments 
In aqueous solution the proton spectrum of cmP18106_137 
showed a poor dispersion, characteristic of a random coil con- 
formation. The 2D NOESY NMR spectrum of this sample 
showed no long range connectivity. Thus, free CAP18106_137 in
the absence of substrate is in an unordered structure, typical 
for most free peptides. Even though the CD spectra showed the 
presence of an ordered secondary structure in the presence 
of lipid A we were unable to determine the structure of 
CAP18106_137/lipid A complex by NMR because of severe line- 
width broadening when lipid A was added to the peptide solution. 
This suggests the formation of large aggregates ofCAP18106_137 / 
lipid A complex under experimental conditions needed for 
NMR study. However, the CD spectrum of a 20/.tM CAP 18106_137 
in 30% (v/v) TFE is very similar to that observed with 
20 pM CAP18t0~137 in 40 pM lipid A (Fig. la). Thus, we have 
determined the structure of CAP1810w137 in 30% TFE. Al- 
though the similarily in CD spectra does not imply structural 
identity, using synthetic peptides or tryptic fragments it has 
been shown in several studies that only those peptides that 
adapt helical conformation i the native protein adopt helical 
conformation i the presence of TFE [12]. These results uggest 
that a peptide's propensity to form a helix is a prerequisite for 
the induction of an ordered helix by TFE. 
We performed a complete series of two-dimensional NMR 
experiments o determine the structure of CAP18t0~I37 in 30% 
TFE at three temperatures, 302K, 31 OK and 315K. Fig. 2 shows 
a representative 'fingerprint' region of a 2D TOCSY spectrum 
at 315K. Twenty-five C~H-NH scalar connectivities are clearly 
observed. Spectra obtained at different emperatures helped to 
resolve the spectral overlap and enabled us to assign all reso- 
nances. By following resonances at more than one temperature 
it was relatively straightforward to assign all the resonances 
using standard sequential resonance assignment strategy [13]. 
Four of the five single amino acids in the sequence were as- 
signed first (F9, N 11, P29 and A32). A32 was assigned from its 
unique COSY cross-peak between C=H and C,~H 3. P29 was 
identified from TOCSY relayed cross-peaks C~H-C~H2. The 
two AMX spin systems ofF9 and N11 were distinguished from 
the NOESY spectrum, based on the C6H2-CBH 2 connectivities 
for F9. The two glycines (G21 and G26) were identified from 
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Fig. 2. Representative 213 TOCSY NMR spectrum of  the 'fingerprint' 
region at 80 ms mixing time, showing the long range connectivities. 
Sample contains 2 mM CAPl8106-137 in ]0 mM phosphate buffer, pH 
3.5, in H20/D2OFEFE = 60:10:30 (v/v/v) solvent at 3 ! 5K. The assign- 
ments are also given on the spectrum. 
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Fig. 3. Summary of the sequential connectivities and backbone amide proton exchange rates of CAP18106_137. The bar thickness i proportional to 
the cross-peak intensity. Most of the amide protons, marked with filled circles, do not exchange over a period of several weeks. The exceptions are: 
(i) the amide proton of the N-terminal glycine, marked with an 'X', exchanges rapidly; (ii) the amide protons of four amino acids, marked with 
half-moon circles, lost 70-80% of their intensities in several days. 
DQF-COSY spectrum. The spin systems of El5, Q22 and Q25 
were identified from the TOCSY experiment where the remote 
connectivities, NH-flCH2 were easily identified. The spin sys- 
tems of the three Is and six Ls can be identified from the upfield 
region of the TOCSY and DQF-COSY spectra. The spin sys- 
tems of Rs and Ks were assigned from the connectivity patterns 
of C~H-C,H2 for arginine and C~H-C,H2 for lysine. These as- 
signments were reconfirmed from the cross-peaks between NH 
and side chain protons of Arg and Lys in the downfield region. 
Sequential assignments were done on the basis of four sets 
of NOESY spectra t different emperatures and mixing times 
(80 ms mixing time at 296K, 100 and 300 ms at 302K, and 300 ms 
at 310K). Under these conditions most of the unresolved 
nOes were well-resolved. Although most of the assignments 
were straightforward, the weak sequential nOes of K12 NH to 
N i l  C~H and K14 NH to 113 C~H were problematic. The 
NH~-NHi ÷ ~ nOes at different emperatures helped to resolve 
the confusion. The final assignments are listed in supplemen- 
tary material. 
3.3. Conformation o f  CAP181o 6 137 
Fig. 3 shows a summary of the nOe connectivities of back- 
bone protons and the exchange rates of backbone amide pro- 
tons at pH 3.5 in 30% TFE. The observation of several nOe 
cross-peaks, including those of NHi-NHi+I, C~Hi-NHi+I, 
C~Hi -NHi+3,  CaHi - f /~Hi+3,  and C~Hi -NHi+ 2 nOes throughout 
the peptide is indicative of a molecule with a helix structure. 
The observation of weak C~Hi- NH~+4 cross-peaks further 
suggests that it is an a-helix, rather than a 3~0-helix. Since only 
C~H(L28) - C~H 2 (P29) nOe was observed, the proline-29 is 
likely to be in a trans conformation. 
The cross-peak intensities of the 100 ms mixing time NOESY 
spectrum, obtained at 302K, were used to calculate the upper- 
boundary of the inter-proton distances. These distances were 
calibrated using a calibration curve based on the known dis- 
tances of methylene protons and aromatic protons. According 
to this procedure the nOe peak intensities were assigned is- 
tances of 2-2.7/~, 2 3.3 A, 2.54.0/~, and 3.0-5.0 ~ depending 
on whether the cross-peak intensities were very strong, strong, 
medium or weak, respectively. Due to lack of stereospecific 
assignments, pseudoatoms were used whenever stereospecific 
protons were encountered [13]. From two-dimensional NOESY 
spectra obtained at different emperatures we obtained a total 
of 263 interproton restraints, including 90 inter-residue back- 
bone proton restraints and 63 inter-residue sidechain proton 
restraints. Because of the intrinsic broad linewidth we did not 
use  3JNHct o calculate torsional angle c#. 
Three-dimensional structures of CAP181o6_137 were deduced 
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Fig. 4. (a) Superimposition f fifteen backbone structures of CAPI 8~0~-t37 deduced from 263 nOe constraints and refined with simulated annealing 
protocol in XPLOR program. The fifteen structures have the lowest overall energies and contain o single nOe violation greater than 0.3/~,. (b) Helical 
wheel plot of CAPI 8~0¢t37 showing the clustering of positively charged groups and the hydrophobic groups. 
using the 263 nOe distance constraints by the dynamical simu- 
lated annealing method using the XPLOR program. The force 
field employed for structure calculation consists of only three 
terms: the covalent term which maintains correct bond lengths, 
angles, chiralities and planarities; the non-bonded interaction 
which is represented by the van der Waals repulsion term; and 
the nOe distance restraint erm which is represented by a 
square-well potential. Three starting structures, ~-helix, ex- 
tended, and random coil, were employed to generate 300 struc- 
tures. The violation in nOe constraints and the total energy of 
each structure were calculated. The computed structures were 
inspected on a Silicon Graphic workstation model 4D35/TG 
using the INSIGHT II program. Structures which contained 
too many nOe violations and had high final energies were 
discarded. Fifteen structures with no single nOe violation larger 
than 0.3 /~ (average RMSD = 0.054 /~) and lowest energies 
were overlaid and are shown in Fig. 4a. The whole CAP18106_137 
molecule forms a nearly straight helix. We found that structures 
with larger bending have higher energy and more severe nOe 
violations. The coordinates of the structure has been deposited 
in Brookhaven Protein Data Bank (Identification umber 
1 LYP). 
3.4. Stability of the helix 
The stability of the helix can be deduced from the exchange 
rate of the amide protons, i.e. the rate of decrease in intensities 
when the solvent was changed from H20 to D20 in the 2D 
TOCSY spectra, the results for which are shown in Fig. 3. The 
intensity of most amide protons did not change after several 
days in D20 , with the exception of the intensities of the K14, 
L17, G21 and G26 residues which decreased 70-80% in the 
same time period. Thus the helix is extremely stable even at 
those few more flexible sites. The stability of the helix is further 
demonstrated in the high melting temperature of the peptide, 
as indicated by the presence of sharp exchangeable amide pro- 
ton resonances at a temperature as high as 77°C (figure not 
shown). Using the aromatic proton resonances between 7.5 ppm 
and 8.0 ppm as references, we estimate that roughly 50% of the 
amide proton intensity is still observable at 77 ° C. 
3.5. State of lipid A 
Lipid A is an amphipathic molecule possessing a charged 
diphosphoryl glucosamine head group and up to seven hydro= 
phobic fatty acid chains [I]. At present, the details of the mech- 
anism underlying the interaction of lipid A with host cell mem- 
branes or with particular components of the membranes 
leading to well-known biological effects are not well understood. 
All available data suggest hat full endotoxic activity is ex- 
pressed by a molecule containing two (o-gluco-configurated) 
hexosamine r sidues, two phosphoryl groups, and six saturated 
fatty acids including 3-acyloxylated groups with a defined chain 
length and in a distinct location. Whether the endotoxic onfor= 
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mation relates to a single endotoxin molecule or to a peculiar 
aggregation state remains to be elucidated. Evidence also has 
been provided that a highly disaggregated form of Re-LPS 
(possibly the monomer) may function as the active unit [14]. 
Our observation of the drastic broadening of the proton 
NMR resonances of the CAP18106_I37 with no observable pre- 
cipitate formation when lipid A was added to the protein sam- 
ple suggests that under the experimental conditions for NMR 
at millimolar concentration the lipid A molecules exist in large 
aggregated structures, not in monomeric or other lower order 
forms. On the other hand, at the micromolar concentration 
range employed for our CD study, lipid A appears to form 
more than one kind of complex with CAP18106 137. This is indi- 
cated by the lack of an isosbestic point for the CD spectra of 
CAP1810~137 when lipid A was added stepwise, and the observa- 
tion of an isosbestic point at fixed lipid A concentration. While 
it is tempting to fit the helical content curve to obtain binding 
parameters, the lack of information on binding stoichiometry, 
number of species involved and the intrinsic uncertainty associ- 
ated with estimating the helical content from CD curves make 
such an exercise much too speculative at present. 
3.6. Structure of  CAP18jo 6 ~37 in lipid A complex 
No NMR or crystal structure of protein or peptide complex 
with lipid A has been published to date. Studies on the interac- 
tion of small peptides, including polymyxin B, with lipid A 
confirmed that multiple structural factors are responsible for 
optimal binding of the peptide to lipid A, including the am- 
phipathic and cationic features of the primary amino acid se- 
quence, the hydrophobicity, the size of the structure and the 
peptide conformation [15]. From the X-ray crystal structure of 
the LPS binding protein, LALF an amphipathic loop was pro- 
posed as the LPS binding motif [6]. This loop is distinguished 
by an alternating series of positively charged and hydrophobic 
residues that, by virtue of the extended fl-conformation, point 
in opposite directions, and a single pair of positive charges that, 
because of the fl-turn conformation, point in the same direction 
and maintain the amphipathicity. Similar structures have been 
proposed for two other mammalian LPS binding proteins, LBP 
[16] and BPI [17]. The present CD work is the first to show that 
indeed CAP18106_[37 adapts a helical conformation when bound 
to lipid A. The 'model' structure of CAP1810~137 in 30% (v/v) 
rFE  determined by NMR further evealed that the helix spans 
the whole molecule and is very rigid. However, it should be 
pointed out that since CAP18~0~37 can assume different struc- 
tures at different lipid A concentration the structure determined 
in TFE is probably better esembles that observed in high lipid 
A concentration. Our result is consistent with previous obser- 
vations that peptides with higher helical propensity also possess 
tfigher antimicrobial ctivity [10]. Our observation of a com- 
plete helical structure for CAP1810~137 is in contrast to that of 
LALF but is similar to that of many membrane peptides [17] 
~ncluding melittin [18], magnin 2 [19], and cercropins [20]. In 
~omparison with melittin, CAP18j0~137 is much more hydro- 
~hilic. From the helical wheel projection of the peptide shown 
n Fig. 4b we found patches of positively charged residues 
including 11 of the first 19 residues near the N-terminus. These 
positively charged groups span an angle of 260 ° . For residues 
~aear the C-terminus, residues 20-32 there are 9 bydrophobic 
residues panning an angle of over 220 ° . For the whole mole- 
-ule the hydrophobic residues pan an angle of about 100 °. 
Such a special arrangement of the amino acid residues renders 
it equally favorable for the CAP1810w137 molecule to bind to 
either the negatively charged iphosphoryl groups or the hy- 
drophobic fatty acyl chains. Preliminary computer modeling 
showed that the positively charged groups are separated by 
distances optimal for interaction with the two negatively 
charged iphosphoryl groups at 10.9/k apart. We hypothesize 
that the major impetus for forming the helix structure is to form 
charged or hydrophobic patches and stripes, thus explaining 
the observation that variants of the 20-residue peptide corre- 
sponding to residues 106-125 of CAP18, CAPI8106 ~25, with 
higher helical propensity are also more potent antimicrobial 
agents [10]. 
Other hints on the mechanism of the interaction between 
CAP18~0~3v and lipid A can be found from comparing the 
activity of various CAP18 peptides with different lengths and 
mutations. Among the published CAPI8 peptides CAP18~06 137 
appears to be the most potent antimicrobial peptide, with an 
IC50 of 20 nM against Salmonella minnesota R595 strain [9], 
higher than CAP18,~6.125 and its variants [10]. This suggests that 
the additional interaction due to the C-terminus hydrophobic 
residues in CAP18~0~37 plays a major role in CAPI8 binding 
to lipid A, Replacing the two positively charged residues, Arg-5 
and Lys-16, with alanine, which has high helix propensity and 
is hydrophobic, resulted in increased antibacterial ctivity and 
faster kinetics of permeabilization. This finding further indi- 
cates the importance of hydrophobic nteraction and the helical 
conformation. 
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